CATALOGO DEI PRODOTTI DELLA RICERCA

SENNA, GIANENRICO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 2.431
EU - Europa 1.969
AS - Asia 785
SA - Sud America 5
AF - Africa 4
Continente sconosciuto - Info sul continente non disponibili 4
OC - Oceania 2
Totale 5.200
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 2.420
CN - Cina 701
GB - Regno Unito 450
IT - Italia 421
FR - Francia 269
IE - Irlanda 253
SE - Svezia 244
DE - Germania 163
FI - Finlandia 89
VN - Vietnam 28
UA - Ucraina 23
BE - Belgio 17
IN - India 14
RU - Federazione Russa 11
TR - Turchia 11
KR - Corea 10
CA - Canada 7
JP - Giappone 6
CH - Svizzera 5
HK - Hong Kong 5
AT - Austria 4
ES - Italia 4
NL - Olanda 4
MX - Messico 3
SG - Singapore 3
A2 - ???statistics.table.value.countryCode.A2??? 2
AE - Emirati Arabi Uniti 2
AR - Argentina 2
AU - Australia 2
BG - Bulgaria 2
CL - Cile 2
EG - Egitto 2
EU - Europa 2
LV - Lettonia 2
SA - Arabia Saudita 2
BA - Bosnia-Erzegovina 1
BY - Bielorussia 1
CR - Costa Rica 1
CZ - Repubblica Ceca 1
HR - Croazia 1
KG - Kirghizistan 1
LK - Sri Lanka 1
MA - Marocco 1
MD - Moldavia 1
NO - Norvegia 1
PE - Perù 1
PL - Polonia 1
SC - Seychelles 1
SK - Slovacchia (Repubblica Slovacca) 1
TH - Thailandia 1
Totale 5.200
Salva come PNG Salva come JPEG
Città #
Chandler 626
Southend 422
Dublin 249
New York 212
Beijing 168
Jacksonville 157
Woodbridge 145
Ashburn 117
Lawrence 109
Princeton 109
Wilmington 90
Verona 84
Houston 76
Ann Arbor 75
Sindelfingen 74
Jinan 60
Shenyang 53
Helsinki 42
Nanjing 38
Redmond 37
Hebei 36
Bologna 27
Redwood City 27
Ningbo 24
Changsha 23
Haikou 21
Nanchang 21
Norwalk 21
Seattle 21
Tianjin 21
Dong Ket 20
Guangzhou 20
Taizhou 19
Rome 18
Milan 17
Taiyuan 17
Hangzhou 16
Zhengzhou 16
Brussels 14
Jiaxing 10
Lanzhou 10
Seoul 10
Falls Church 9
Lancaster 8
Padova 8
Lappeenranta 7
Los Angeles 7
Palermo 7
Chicago 6
Detroit 6
Enterprise 6
Fuzhou 6
Fairfield 5
Washington 5
Ancona 4
Arco 4
Bari 4
Boydton 4
Clearwater 4
Delhi 4
Hyderabad 4
Monserrato 4
San Martino Buon Albergo 4
Toronto 4
Trecate 4
Treviso 4
Bollate 3
Boston 3
Busto Garolfo 3
Chions 3
Dearborn 3
Dongguan 3
Genoa 3
Istanbul 3
Madrid 3
Negrar 3
Riva 3
Santeramo in Colle 3
Texas City 3
Trento 3
Turin 3
Abbiategrasso 2
Acquedolci 2
Altopascio 2
Amsterdam 2
Barnet 2
Boardman 2
Breganze 2
Brescia 2
Cagliari 2
Cambridge 2
Canberra 2
Ceranova 2
Chennai 2
Cologna Veneta 2
Como 2
Cortona 2
Dubai 2
Düsseldorf 2
Florence 2
Totale 3.583
Salva come PNG Salva come JPEG
Nome #
Dupilumab-induced hypereosinophilia: review of the literature and algorithm proposal for clinical management 150
Bone mineral density, bone turnover markers and fractures in patients with indolent systemic mastocytosis 96
Drop-out rate among patients treated with omalizumab for severe asthma: Literature review and real-life experience 85
Periostin: The bone and beyond 83
Allergen specific immunotherapy is safe and effective in patients with systemic mastocytosis and hymenopteria allergy 81
Study on the Immunoreactivity of Triticum monococcum (Einkorn) Wheat in Patients with Wheat-Dependent Exercise-Induced Anaphylaxis for the Production of Hypoallergenic Foods 81
La salute del respiro: epidemiologia, costi sanitari ed implicazioni sociali delle malattie respiratorie croniche in Europa e in Italia 79
Clonal mast cell disorders in patients with systemic reactions to Hymenoptera stings and increased serum tryptase levels 78
Impatto socio-sanitario e livello del controllo delle patologie respiratorie croniche ostruttive e della rinite in Italia 74
Scombroid syndrome: it seems to be fish allergy but... it isn't 69
Fatal asthma; is it still an epidemic? 67
Analysis of the positivity rate in IgE positive patients to inhalant allergens in Verona Hospital Laboratory during 2002-2003 67
Wasp venom allergy screening with recombinant allergen testing. Diagnostic performance of rPol d 5 and rVes v 5 for differentiating sensitization to Vespula and Polistes subspecies 66
A double-blind placebo-controlled study on the diagnostic accuracy of an electrodermal test in allergic subjects 65
Allergy and the bone: unexpected relationships 65
Is hymenoptera venom allergy an occupational disease? 64
Omalizumab management beyond clinical trials: the added value of a network model 63
How much specific is the association between hymenoptera venom allergy and mastocytosis? 63
Asthmatic patients in COVID-19 outbreak: Few cases despite many cases 63
What lies beyond Asthma Control Test: Suggestions for clinical practice 62
Allergic Reactions to COVID-19 Vaccines: Risk Factors, Frequency, Mechanisms and Management 60
Potential benefit of omalizumab in respiratory diseases 60
The degree of serological sensitization to cat allergen in patients with or without cat at home 60
Allergic rhinitis: pharmacotherapy in pregnancy and old age 59
SANI-Severe Asthma Network in Italy: a way forward to monitor severe asthma 59
Adverse reaction to local anaesthetics: Is it always allergy? 59
Thunderstorm Asthma: A Critical Appraisal Based on Clinical Practice 58
Systemic Reactions After Hymenoptera Sting And Raised Serum Tryptase Strongly Suggest Clonal Mast Cells Disorders 57
Asthma in a large COVID-19 cohort: Prevalence, features, and determinants of COVID-19 disease severity 57
Biologics for Eosinophilic Granulomatosis with Polyangiitis: one size does not fit all 56
COVID-19 in severe asthmatic patients during ongoing treatment with biologicals targeting type 2 inflammation: Results from a multicenter Italian survey 55
Asthma control in primary care: the results of an observational cross-sectional study in Italy and Spain 54
Allergen Immunotherapy Adherence in the Real World: How Bad Is It and How Can It Be Improved? 54
Biologic Therapy in a Patient with Asthma and Nasal Polyps 53
Low adherence to inhaled corticosteroids/long-acting β2-agonists and biologic treatment in severe asthmatics 52
Onset of eosinophilic granulomatosis with polyangiitis in a patient treated with an IL-5 pathway inhibitor for severe asthma 51
IgE to staphylococcal enterotoxins are undetectable in sera from patients with nasal polyposis 50
Mepolizumab 100 mg in severe asthmatic patients with EGPA in remission phase 49
Relevance of TH2 markers in the assessment and therapeutic management of severe allergic asthma: A real-life perspective 48
Reslizumab and Eosinophilic Asthma: One Step Closer to Precision Medicine? 47
Timing of response and long term efficacy of Omalizumab in non-clonal Mast Cell Activation Syndrome: A case series 47
Asthma management among different specialists: results from a national Italian survey 47
Safety of uSCIT-MPL-4: prevalence and risk factors of systemic reactions in real life 46
How far from correct is the use of adrenaline auto-injectors? A survey in Italian patients 46
New horizons for the treatment of severe, eosinophilic asthma: benralizumab, a novel precision biologic 46
Incidence and risk factors for subcutaneous immunotherapy anaphylaxis: the optimization of safety 45
COPD prevalence in a north-eastern Italian general population 45
Component resolved diagnosis (CRD): how much is it presently used by Italian allergists? 44
Evaluation of the IgE cross-reactions among vespid venoms. A possible approach for the choice of immunotherapy 43
Eosinophilic Granulomatosis With Polyangiitis and Cardiac Involvement: A Case Report 43
Biologic Therapy in a Patient with Asthma and Nasal Polyps 43
Asthma under/misdiagnosis in primary care setting: an observational community-based study in Italy 43
BCG vaccination and COVID-19: Much ado about nothing? 43
Evaluation of asthma control in the pharmacy: an Italian cross-sectional study 42
Mepolizumab for severe eosinophilic asthma: a real-world snapshot on clinical markers and timing of response 42
Residual Lung Function Impairment Is Associated with Hyperventilation in Patients Recovered from Hospitalised COVID-19: A Cross-Sectional Study 42
Asthma management among allergists in Italy: results from a survey 41
Biologics and global burden of asthma: A worldwide portrait and a call for action 41
Uncontrolled Asthma: Unmet Needs in the Management of Patients 41
Treatment with American Polistes venom was ineffective in an Italian patient allergic to European Polistes 40
Immunoblotting study of specific antibody patterns against latex and banana 40
Chronic Urticaria Patient Perspective (CUPP): The First Validated Tool for Assessing Quality of Life in Clinical Practice 40
Balancing efficacy against safety in sublingual immunotherapy with inhalant allergens: what is the best approach? 40
Trends and determinants of Emergency Room admissions for asthma: A retrospective evaluation in Northeast Italy 40
Emerging drugs for allergic conjunctivitis 40
The potential role of local pharmacies to assess asthma control: an Italian cross-sectional study 40
Importance of Cardiopulmonary Exercise Testing amongst Subjects Recovering from COVID-19 40
Relationship between hair shedding and systemic inflammation in COVID-19 pneumonia 40
Targeting eosinophils: severe asthma and beyond 39
Anaphylaxis and intimate behaviour 39
Efficacy of Benralizumab in severe asthma in real life and focus on nasal polyposis 39
Multidisciplinary management in type 2 inflammatory disease 39
Orphan immunotherapies for allergic diseases 38
Asthma control in severe asthmatics under treatment with omalizumab: A cross-sectional observational study in Italy 38
Serum periostin during omalizumab therapy in asthma: A tool for patient selection and treatment evaluation 36
Biologics for the Treatments of Allergic Conditions 36
Sex in Respiratory and Skin Allergies 35
Oral health in asthmatic patients: a review 35
Clinical features associated with a doctor-diagnosis of bronchiectasis in the Severe Asthma Network in Italy (SANI) registry 35
Effect of α1 Antitrypsin Deficiency on Lung Volume Decline in Severe Asthmatic Patients Undergoing Biologic Therapy 35
The role of the pharmacy in the management of bronchial asthma: A literature-based evaluation 34
Use of complementary medicine among patients with allergic rhinitis: an Italian nationwide survey. 34
Comment on: Onset of eosinophilic granulomatosis with polyangiitis in a patient treated with an IL-5 pathway inhibitor for severe asthma: reply 34
Clinical response to biologicals for severe asthma: any relevance for sex in different age ranges? 33
ALLERGY AND CORONAVIRUS DISEASE (COVID-19) INTERNATIONAL SURVEY: REAL-LIFE DATA FROM THE ALLERGY COMMUNITY DURING THE PANDEMIC 33
Oral CorticoSteroid sparing with biologics in severe asthma: A remark of the Severe Asthma Network in Italy (SANI) 32
Prevalence and features of asthma-chronic obstructive pulmonary disease overlap in Northern Italy general population 31
Who Is Really at Risk for Anaphylaxis Due to COVID-19 Vaccine? 31
Spontaneous pneumomediastinum complicating severe acute asthma exacerbation in adult patients 30
Safety and tolerability of sublingual immunotherapy in clinical trials and real life 29
Respiratory allergies in childhood: Recent advances and future challenges 29
OCCUPATION study (OCCUPationl asthma: a naTIONal based study): a survey on occupational asthma awareness among Italian allergists 29
Choosing wisely: practical considerations on treatment efficacy and safety of asthma in the elderly 28
Minimal clinically important difference for asthma endpoints: an expert consensus report 28
Reconsidering anaphylaxis at the time of COVID-19 pandemic 28
COVID-19 Vaccination in Patients with Severe Asthma on Biologic Treatment: Safety, Tolerability, and Impact on Disease Control 28
One-year mepolizumab for Allergic bronchopulmonary aspergillosis: Focus on steroid sparing effect and markers of response 28
Omalizumab for severe allergic asthma in clinical trials and real-life studies: what we know and what we should address 27
COVID-19 pandemic and environment: Not only air pollution 24
Benralizumab Efficacy in Late Non-Responders to Mepolizumab and Variables Associated with Occurrence of Switching: A Real-Word Perspective 23
Totale 4.846
Salva come PNG Salva come JPEG
Categoria #
all - tutte 22.777
article - articoli 22.347
book - libri 221
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 209
Totale 45.554
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/201916 0 0 0 0 0 0 0 0 0 0 12 4
2019/2020427 50 2 1 15 39 48 25 14 14 92 78 49
2020/2021655 78 119 20 92 118 71 17 31 21 8 50 30
2021/2022712 85 172 19 45 16 14 15 48 50 13 51 184
2022/20231.844 139 158 190 266 179 421 31 108 222 15 76 39
2023/20241.062 52 92 119 168 114 282 89 63 20 58 5 0
Totale 5.376